APA (7th ed.) Citation

Hachulla, E., Le Masson, G., Solé, G., Hamidou, M., Desnuelle, C., Azulay, J., . . . Gauthier-Darnis, M. (2018). Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study. BioMed Research International, 2018, 1. https://doi.org/10.1155/2018/8147251

Chicago Style (17th ed.) Citation

Hachulla, Eric, et al. "Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study." BioMed Research International 2018 (2018): 1. https://doi.org/10.1155/2018/8147251.

MLA (9th ed.) Citation

Hachulla, Eric, et al. "Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study." BioMed Research International, vol. 2018, 2018, p. 1, https://doi.org/10.1155/2018/8147251.